Annual Results Results Snapshot
Figures in Million
Consolidate Annual Results
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
Mar'18
Mar'17
Net Sales
72.58
73.92
78.80
77.58
89.22
85.76
107.90
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
72.58
73.92
78.80
77.58
89.22
85.76
107.90
Raw Material Cost
41.43
36.37
36.24
34.67
39.62
44.89
65.17
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
16.40
17.55
15.54
21.82
23.74
25.85
26.75
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
15.64
13.23
11.24
9.35
7.82
6.59
5.55
Selling and Distribution Expenses
41.42
55.57
49.55
59.25
66.77
57.81
62.13
Other Expenses
-3.12
-3.03
-2.68
-3.12
-3.16
-3.24
-3.23
Total Expenditure (Excl Depreciation)
83.73
92.38
85.79
93.92
106.38
102.71
127.31
Operating Profit (PBDIT) excl Other Income
-11.200000000000001
-18.5
-7
-16.299999999999997
-17.2
-16.9
-19.4
Other Income
3.58
1.39
6.15
9.79
8.51
90.80
77.67
Operating Profit (PBDIT)
1.09
-8.44
7.23
-0.24
-2.42
80.18
64.69
Interest
15.64
13.23
11.24
9.35
7.82
6.59
5.55
Exceptional Items
157.97
166.28
-104.70
101.38
79.85
-37.73
-33.40
Gross Profit (PBDT)
31.14
37.56
42.57
42.92
49.60
40.87
42.73
Depreciation
8.66
8.63
8.06
6.30
6.24
6.33
6.43
Profit Before Tax
134.75
135.98
-116.78
85.49
63.37
29.19
18.93
Tax
1.13
1.24
0.00
-0.09
0.05
-0.09
0.62
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
129.26
130.59
-121.10
83.28
64.03
29.93
20.80
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
129.26
130.59
-121.10
83.28
64.03
29.93
20.80
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.51
0.50
1.44
2.30
-0.71
-0.66
-2.48
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
129.77
131.09
-119.66
85.58
63.32
29.27
18.31
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.01
0.01
0.01
0.01
0.01
0.01
0.01
Reserves
769.36
653.29
518.15
630.14
554.29
559.21
517.33
Earnings per share (EPS)
0.04
0.04
-0.05
0.03
0.02
0.01
0.01
Diluted Earnings per share
0.04
0.04
-0.05
0.03
0.02
0.01
0.01
Operating Profit Margin (Excl OI)
-15.37%
-24.97%
-8.86%
-21.05%
-19.24%
-19.76%
-17.98%
Gross Profit Margin
197.6%
195.62%
-137.96%
118.31%
78.02%
41.41%
23.5%
PAT Margin
178.11%
176.65%
-153.67%
107.34%
71.77%
34.9%
19.27%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2023 is -1.76% vs -6.22% in Mar 2022
Consolidate Net Profit
YoY Growth in year ended Mar 2023 is -0.99% vs 209.52% in Mar 2022
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2023 is 74.49% vs -990.91% in Mar 2022
Interest
YoY Growth in year ended Mar 2023 is 18.18% vs 17.86% in Mar 2022
Operating Profit Margin (Excl OI)
YoY Growth in year ended Mar 2023 has improved from Mar 2022
Compare Annual Results Of Extrawell Pharmaceutical Holdings Ltd. With
Figures in Million
Consolidate Annual Results
Change(HKD)
Change(%)
Net Sales
72.58
134.92
-62.34
-46.21%
Other Operating Income
0.00
0.00
0.00
Total Operating income
72.58
134.92
-62.34
-46.21%
Raw Material Cost
41.43
96.04
-54.61
-56.86%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
16.40
12.64
3.76
29.75%
Power Cost
0
0
0.00
Manufacturing Expenses
15.64
2.27
13.37
588.99%
Selling and Distribution Expenses
41.42
15.26
26.16
171.43%
Other Expenses
-3.12
-1.49
-1.63
-109.40%
Total Expenditure (Excl Depreciation)
83.73
111.30
-27.57
-24.77%
Operating Profit (PBDIT) excl Other Income
-11.15
23.62
-34.77
-147.21%
Other Income
3.58
0.59
2.99
506.78%
Operating Profit (PBDIT)
1.09
28.65
-27.56
-96.20%
Interest
15.64
2.27
13.37
588.99%
Exceptional Items
157.97
2.82
155.15
5,501.77%
Gross Profit (PBDT)
31.14
38.88
-7.74
-19.91%
Depreciation
8.66
4.49
4.17
92.87%
Profit Before Tax
134.75
24.71
110.04
445.33%
Tax
1.13
9.94
-8.81
-88.63%
Provisions and contingencies
0.00
0
0.00
Profit After Tax
129.26
20.59
108.67
527.78%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
129.26
20.59
108.67
527.78%
Share in Profit of Associates
0.00
0
0.00
Minority Interest
0.51
-5.82
6.33
108.76%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
129.77
14.77
115.00
778.61%
Equity Capital
0
0
0.00
Face Value
0.01
0.00
0.00
Reserves
769.36
291.16
478.20
164.24%
Earnings per share (EPS)
0.04
0.01
0.03
300.00%
Diluted Earnings per share
0.04
0.01
0.03
300.00%
Operating Profit Margin (Excl OI)
-15.37%
17.47%
0.00
-32.84%
Gross Profit Margin
197.60%
21.64%
0.00
175.96%
PAT Margin
178.11%
15.26%
0.00
162.85%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 7.26 Million
in Mar 2023Figures in Million
YoY Growth in year ended Mar 2023 is -1.76% vs -6.22% in Mar 2022
Annual - Consolidate Net Profit
Consolidate Net Profit 12.98 Million
in Mar 2023Figures in Million
YoY Growth in year ended Mar 2023 is -0.99% vs 209.52% in Mar 2022
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) -0.25 Million
in Mar 2023Figures in Million
YoY Growth in year ended Mar 2023 is 74.49% vs -990.91% in Mar 2022
Annual - Interest
Interest 1.56 Million
in Mar 2023Figures in Million
YoY Growth in year ended Mar 2023 is 18.18% vs 17.86% in Mar 2022
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) -15.37%
in Mar 2023Figures in %
YoY Growth in year ended Mar 2023 has improved from Mar 2022
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
